FRX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: N/A

Insider Buying (Last 12 Months): C$6,499.94

Insider Selling (Last 12 Months): C$250,941.70

Fennec Pharmaceuticals Insider Trading History Chart

Fennec Pharmaceuticals Share Price & Price History

C^$13.13

▼ -0.49 (-3.60%)

As of 02/3/2023 01:00 AM ET

Days: 30 | 90 | 365

“Future Fuel” will unleash $11 trillion wave of wealth

From Wall Street Watch Dogs | Ad

The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…

Click here for the full story

Fennec Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/17/2022	Chris Anigeron Rallis	Director	Sell	333	C$10.63	C$3,538.69	30,018
10/20/2022	Chris Anigeron Rallis	Director	Sell	2,068	C$10.66	C$22,035.37	25,589
9/21/2022	Robert Christopher Andrade	Senior Officer	Sell	19,052	C$11.02	C$209,888.26	176,721
9/12/2022	Rostislav Christov Raykov	Director	Sell	16,666	C$0.93	C$15,479.38	21,081,996
7/18/2022	Chris Anigeron Rallis	Director	Buy	11,111	C$0.59	C$6,499.94	32,036
8/17/2020	Robert Christopher Andrade	Senior Officer	Sell	12,874	C$7.99	C$102,914.76	158,273
8/17/2020	Rostislav Christov Raykov	Director	Sell	12,093	C$7.99	C$96,671.44	2,355,838
8/13/2020	Robert Christopher Andrade	Senior Officer	Sell	97,136	C$8.64	C$839,060.77	248,875
8/13/2020	Rostislav Christov Raykov	Director	Buy	323,961	C$1.85	C$599,327.85	2,541,011

Cash Holders STILL Aren't Taking Steps to Prepare

From Investor Place Media | Ad

Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.

Click Here to Learn More

SEC Filings (Institutional Ownership Changes) for Fennec Pharmaceuticals (TSE:FRX)

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.

Today's Range

Now: C$13.13

C$13.13

50 Day Range

MA: C$13.36

C$12.27

C$14.41

52 Week Range

Now: C$13.13

C$5.94

C$14.41

Volume

118 shs

Average Volume

648 shs

Market Capitalization

C$344.81 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Fennec Pharmaceuticals?: Fennec Pharmaceuticals' top insider shareholders include:
Rostislav Christov Raykov (Director)
Robert Christopher Andrade (Senior Officer)
Chris Anigeron Rallis (Director)
Learn More about top insider investors at Fennec Pharmaceuticals.